All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Hims Better Option Than 2026

Is there a better option than Hims for GLP-1 therapy in 2026? We compare programs that offer deeper clinical care, broader medication options, and more...

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Hims Better Option Than 2026 custom 2026 header image for Provider Comparisons
Custom header image for Hims Better Option Than 2026, Provider Comparisons, and better treatment decision-making.
In This Article

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Search and AI answer brief

Practical answer: Hims Better Option Than 2026

Is there a better option than Hims for GLP-1 therapy in 2026? We compare programs that offer deeper clinical care, broader medication options, and more...

Short answer

Is there a better option than Hims for GLP-1 therapy in 2026? We compare programs that offer deeper clinical care, broader medication options, and more...

Search intent

This page answers a specific Provider Comparisons question rather than a generic overview.

What to verify

semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Is there a better option than Hims for GLP-1 therapy in 2026? We compare programs that offer deeper clinical care, broader medication options, and more personalized treatment.

Hims has become synonymous with accessible telehealth. Their GLP-1 weight loss program brought compounded semaglutide and tirzepatide to a massive audience, and the operational execution is impressive. The app works. The medication ships. The billing is straightforward.

But operational excellence isn't the same as clinical excellence. And for a growing number of patients, the question isn't whether Hims delivers medication reliably, but whether it delivers the quality of medical care they actually need.

We compared Hims against the top GLP-1 programs in 2026 to find out where patients can genuinely do better.

Why People Ask If There Is Something Better Than Hims

The search for something better usually starts with a specific unmet need:

  • Provider interactions feel like a formality. When your consultation is five minutes and the physician doesn't remember your case, you start wondering whether you're really being managed or just being prescribed.
  • Standard protocols aren't working. Hims follows a general titration schedule that works for most patients. But "most" isn't "all," and patients who respond differently need a provider willing to deviate from the playbook.
  • Side effects aren't being addressed. Nausea, constipation, and other GLP-1 side effects are common. When your provider's response is to push through rather than adjust, patients rightfully look for better clinical care.
  • Limited treatment scope. Weight management is increasingly understood as a multi-faceted challenge. Patients who want peptide therapies, combination protocols, or treatments that address inflammation and gut health alongside weight loss need a broader formulary.
  • Progress has stalled. The first few months on a GLP-1 produce dramatic results for most patients. When the rate of progress slows, the quality of your clinical team becomes the difference between continued progress and a permanent plateau.

Programs That Offer a Better Experience Than Hims

1. FormBlends: Best for Patients Who Want a Real Physician Relationship

The biggest difference between FormBlends and Hims is the clinical model. At FormBlends, a licensed physician designs your protocol from the start, monitors your response over time, and makes adjustments based on how you're actually doing. This isn't a conveyor belt. It's individualized medical care delivered through a telehealth platform. For a complete cost breakdown, see our cheapest GLP-1 without insurance.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92From $299/mo, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus
Illustration for Hims Better Option Than 2026

The formulary is another major differentiator. FormBlends offers compounded semaglutide ($199/month), tirzepatide ($249/month), and peptide therapies including BPC-157. Patients who want a thorough approach to their health, not just a weight loss prescription, have options here that Hims simply doesn't provide.

Pricing is flat and transparent. No dose-based increases, no hidden consult fees, and no contracts. For patients on higher doses, FormBlends may actually be cheaper than Hims despite the higher base price.

Better than Hims for: Physician engagement, personalized protocols, peptide therapy, flat-rate pricing

Not as strong as Hims for: App polish, brand recognition, scale

2. Ro Body: Best for Patients Who Want Lab-Driven Care

Ro takes medical oversight seriously. Lab monitoring is a standard part of their GLP-1 program, which means dosing decisions are informed by blood work, not just patient self-reports. Their in-house pharmacy adds a layer of quality assurance that independent compounding partnerships can't always match.

For patients who felt that Hims' clinical model was too superficial, Ro offers a meaningfully more rigorous approach. The tradeoff is that costs increase at higher doses and state availability is limited.

Better than Hims for: Lab-based monitoring, clinical rigor, pharmacy quality control

Not as strong as Hims for: Starting price consistency, nationwide availability

3. Calibrate: Best for Patients Who Want a thorough Health Program

Calibrate doesn't just prescribe medication. Their program integrates GLP-1 therapy with nutrition coaching, exercise programming, sleep improvement, and behavioral health support. For patients who believe that medication alone won't produce lasting results, Calibrate offers the most thorough approach on the market.

The cost reflects that breadth. Calibrate is more expensive than Hims, and the commitment is longer. But for patients who have tried medication-only approaches and found them insufficient, the added structure can make the difference.

Better than Hims for: Lifestyle integration, behavioral support, long-term habit change

Not as strong as Hims for: Affordability, flexibility, simplicity

4. MEDVi: Best for Patients Who Want a Focused Weight Loss Platform

Where Hims is a general telehealth platform that happens to offer GLP-1 therapy, MEDVi is built specifically around weight management. That focus translates to a slightly more attentive clinical experience for weight loss patients. Pricing is competitive, and the enrollment process is straightforward.

Better than Hims for: Weight loss focus, dedicated program design

Not as strong as Hims for: Platform maturity, operational reliability, scale

5. WeightWatchers Clinic: Best for Patients Who Want Community Support

WeightWatchers Clinic combines GLP-1 prescribing with the support community that WeightWatchers is known for. For patients who thrive with group accountability and structured programs, this combination addresses the isolation that medication-only approaches can create.

Better than Hims for: Community support, structured programming, accountability

Not as strong as Hims for: Clinical depth, medication variety, cost

Comparison Table

Program Monthly Cost Clinical Model Medications Peptides Best For
FormBlends $199+ Physician-led, personalized GLP-1s + peptides Yes Individualized care
Ro Body $149+ Lab-driven, evidence-based GLP-1s No Clinical rigor
Calibrate $150+ thorough metabolic GLP-1s No Lifestyle integration
MEDVi $149+ Weight loss focused GLP-1s No Dedicated weight loss
WW Clinic Varies Community-supported GLP-1s No Group accountability

Who Should Look for a Better Option Than Hims

Hims is perfectly adequate for a certain type of patient. But consider upgrading if:

Not sure which GLP-1 is right for you?

Take a 2-minute assessment and get a personalized recommendation after licensed provider review.

Take the Assessment →
  • You need more than a prescription. If your current clinical experience amounts to a quick approval and a recurring shipment, you aren't getting medical management. You're getting a subscription. Programs like FormBlends and Ro provide the kind of ongoing physician involvement that produces better, safer outcomes.
  • Your weight loss has stalled. Plateaus require clinical intervention, not patience. If your Hims provider isn't actively adjusting your protocol, a physician-led program may restart your progress.
  • You want peptide therapy. Hims doesn't offer BPC-157 or other therapeutic peptides. If your health goals extend beyond weight loss, you need a provider with a broader formulary.
  • Side effects are affecting your quality of life. GLP-1 side effects should be managed, not tolerated. A more engaged physician can adjust your dose, timing, or medication to reduce side effects while maintaining efficacy.
  • You're paying more than you expected. If dose-dependent pricing has pushed your costs higher than anticipated, flat-rate alternatives may be both better and cheaper.

Frequently Asked Questions

Is Hims bad for GLP-1 therapy?

No. Hims is a legitimate, well-run platform that works for many patients. The question is whether it provides the level of care you specifically need. For patients who need minimal clinical interaction and prioritize convenience, Hims is fine. For patients who need personalized medical management, other programs are stronger.

What is the main weakness of Hims' GLP-1 program?

The high-volume clinical model. Hims processes a large number of patients, which means provider interactions tend to be brief and standardized. Patients who need individualized attention or complex dosing adjustments may find the experience insufficient.

Can I get peptide therapy through Hims?

No. As of 2026, Hims doesn't offer peptide therapies like BPC-157. Patients interested in peptides need to work with a provider that has a broader formulary, such as FormBlends.

Will switching from Hims to another program disrupt my treatment?

Not if you plan the transition properly. Enroll with your new provider and confirm your prescription before canceling Hims. Most patients can switch without any gap in medication.

Key Points

Hims built a good platform for delivering GLP-1 medications at scale. But "good enough" isn't the same as "best for you." If you want deeper clinical care, access to peptide therapies, or pricing that doesn't increase with your dose, the 2026 market has options that outperform Hims in the areas that matter most to your health.

Want a physician who actually manages your care? FormBlends pairs you with a licensed physician for personalized GLP-1 and peptide therapy. No volume-driven shortcuts, no contracts, no dose-based price increases.

Talk to a licensed provider

Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.

Start the assessment →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Calibrate official source
Official source
Found official source
Official source
Hers official source
Official source
Hims official source
Official source
MEDVi official source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Hims Better Option Than 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

Hims Better Option Than 2026 should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Is there a better option than Hims for GLP-1 therapy in 2026? We compare programs that offer deeper clinical care, broader medication options, and more personalized treatment. "Hims Better Option Than 2026" is meant to make a complicated topic easier to discuss, not to flatten it into a one-size answer. FormBlends frames it around patient education and clinical context, with extra attention to provider access. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the next step affects treatment or sourcing, use the article to prepare questions for a licensed clinician.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Hims Better Option Than 2026

For this provider comparisons page, the 2026 refresh focuses on semaglutide, tirzepatide, BPC-157, cash-pay pricing, safety signals, hims so the article stays close to the question behind "Hims Better Option Than 2026".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Hims Better Option Than 2026 from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Hims Better Option Than 2026 custom 2026 image for provider comparisons on FormBlends

Custom 2026 image for Hims Better Option Than 2026, provider comparisons, and better treatment decision-making.

Image description: Unique image for this page covering Hims Better Option Than 2026, provider comparisons, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.